Istesso

Regenerative Medicine

Overview

Istesso is developing adaptive repair medicines which repair and regenerate tissues to treat, resolve and prevent chronic disease and extend healthspan.

Funding and backers

Latest round
Venture round
Feb 2026 · 9 mo ago
Backers
1
Parkwalk Advisors
The money's age
Fresh money
9 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 2 Raised a round Venture round Apr 28, 2023 Raised a round Venture round Feb 28, 2022 Raised a round Venture round Jul 16, 2019 Raised a round Venture round Jan 31, 2019 Raised a round Venture round Jun 30, 2017 Raised a round Venture round
Funding rounds
RoundDateAmountInvestorsSource
Venture round Feb 2026 — — find-and-update.company-information.service.gov.uk
Venture round Apr 2023 — — find-and-update.company-information.service.gov.uk
Venture round Feb 2022 — — find-and-update.company-information.service.gov.uk
Venture round Jul 2019 — — find-and-update.company-information.service.gov.uk
Venture round Jan 2019 — — find-and-update.company-information.service.gov.uk
Venture round Jun 2017 — — find-and-update.company-information.service.gov.uk
Registers and programsofficial lists and records that name the company
Legal entity Istesso Limited its site
Backed byfrom the funds' portfolios and accelerator catalogs
Parkwalk Advisors fund
Investors in similar startupsfunds that back the companies most like this one
NEA
backs Tunetx
Oxford Technology
backs Curileum
better ventures
backs Cellbricks
VU Venture Partners
backs Cellbricks
The Trendlines Group
backs CoreBone
Fund+
backs Novadip
Similar startupsby what they do, their industry and backers
CellbricksVenture round · 8 mo ago · Founded 2016 · 11-50 employees · 1 role
Cellbricks Therapeutics is a biotechnology company that produces bioengineered, implantable human tissue to restore organ and tissue…
FluidForm BioVenture round $1.7M · 3 mo ago · Founded 2018 · 1-10 employees
We build living human tissue using cells, proteins, and nothing else. Our technology leverages the intersection of personalized medicine…
NovadipVenture round $11.2M · 1 mo ago
Novadip is committed to patients and addresses some of today’s biggest challenges in bone and tissue regenerative medicine.
CoreBoneVenture round $3.7M · 5 yr ago · 11-50 employees
CoreBone offers tissue regeneration solutions for Bone and Cartilage from cultivated corals.
CurileumVenture round · 5 mo ago · 51-200 employees
Advancing novel therapies to restore the health of gastrointestinal tissues. Curileum is developing novel therapies that restore the health…
Tunetx
Tune Therapeutics aims to bring gene, cell, and regenerative therapies into a new era of human medicine – expanding their range of…

Financials

Latest round
Venture - Series Unknown
Funding rounds
6
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 — Details
Venture - Series Unknown 2023 — Details
Venture - Series Unknown 2022 — Details
Venture - Series Unknown 2019 — Details
Venture - Series Unknown 2019 — Details
Venture - Series Unknown 2017 — Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
Parkwalk AdvisorsVia a fund
151 portfolio companies: Zetta Genomics, Zentraxa Seed, Zomp and 148 more
Report a mistake